ClinicalTrials.gg
Enrolling by invitationNCT06459011Updated Oct 27, 2026

TAKINGCARE - TAcKlING the Needs of Carers of People With Chronic respirAtoRy disEases

An observational study in Chronic Respiratory Disease, sponsored by Aveiro University. Enrolling by invitation at 1 site in Portugal. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-27.

Sponsored by Aveiro University · Observational

How we know

Updated Oct 27, 2026Now Enrolling by invitation1 site added+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
250
Ages
18 Years and older
Sex
All
01

Study summary

This study aims to: i) develop an instrument that assesses the needs of informal carers of people with chronic respiratory diseases (CRD), along diseases' trajectory, and evaluate its measurement properties; ii) identify existing instruments that assess the needs of informal/family carers and their measurement properties, iii) characterize the needs of informal carers of people with CRD and iv) characterize the health literacy of informal carers of people with CRD.

The first task will be a systematic review. For the second and third tasks, people with CRD, their informal carers and health professionals will be recruited via the pulmonology services from the hospitals:Unidade Local de Saúde de Gaia/Espinho, Unidade Local de Saúde da Região de Aveiro, and Unidade Local de Saúde de Entre o Douro e Vouga. On task 2, a mixed-methods study will be conducted to characterize the needs of informal carers of people with CRD, as well as their health literacy. On task 3, an instrument that assesses the needs of informal carers of people with CRD will be developed and its measurement properties will be studied.

This study is urgently needed to provide meaningful support to this hidden workforce who provides most of the care to people with DRC contributing to guide meaningful supportive care to this population and their loved ones.

Read the detailed description

Chronic respiratory diseases (CRD) are the 3rd leading cause of death and disability worldwide, with high burden for individuals, but also for their families and society, including health services. They are systemic, with pulmonary and extrapulmonary manisfestations, and are characterized by a progressive decline on multiple activities of daily living making this people depend on others along diseases' trajectory.

Daily, informal/family carers, who may be relatives, partners, friends or neighbours, with a significant personal relationship with an elderly person or an adult with a disabling chronic disease, are the main source of support of people with CRD. They have a multiplicity of roles in providing physical, financial, psychological/emotional, social, and spiritual support. It is assumed that informal/family carers have the appropriate level of health literacy, disease knowledge, financial security, household conditions, psychological readiness, and medical care abilities to support the person with CRD.

Although they report positive experiences (e.g., personal growth, satisfaction), there has been an acknowledgement of negative impacts (e.g., burden, difficulty in realizing personal interests/projects) and specific needs related to their roles. Nevertheless, their needs are usually unmet and rarely assessed, and they are highly neglected by the social/health system, as well as in research. Assessment of this needs is the first step to provide meaningful support to this hidden workforce who provides most of the care to people with CRD and it has been emphasised by the European Union's recommendations to support and empower informal carers. However, only two instruments have been explicitly designed to assess their needs: the Carers' Alert Thermometer and the Carer Support Needs Assessment Tool (CSNAT), but their routine use is limited, their measurement properties have been scarcely explored and only for COPD, and studies have focused on end-of-life situations.

Therefore, the primary aim of this study is to develop a new instrument to assess the needs of loved ones across CRD' trajectory. Secondary aims are to map available instruments that assess the needs of informal/family carers and their measurement properties, and characterize the needs of informal carers of people with CRD and their health literacy.

This study will be carried out at the University of Aveiro, at the Laboratory of Research and Respiratory Rehabilitation of the School of Health Sciences of the University of Aveiro, at Unidade Local de Saúde de Gaia/Espinho, at Unidade Local de Saúde da Região de Aveiro, and at Unidade Local de Saúde de Entre o Douro e Vouga, in Portugal.

It comprises three tasks: task 1 will consist of a systematic review, in which the instruments that assess the needs of informal/family carers and their measurement properties will be identified; task 2 will be a cross-sectional study where the needs of informal carers of people with CRD and their health literacy will be characterized, through a mixed-methods study, integrating people with CRD, their informal carers, and health professionals; task 3 will be the development of an instrument that assesses the needs of informal carers of people with CRD. The items will be generated based on tasks 1 and 2 and following existing guidelines. The instrument will be pilot-tested, and the measurement properties of the instrument will then be tested in a cross-sectional observational study. On task 2, the Carer Support Needs Assessment Tool v3.0 and the Preparedness for Caregiving Scale will also be translated to European Portuguese.

Adults who are diagnosed with CRD, who are fluent in Portuguese and identify an informal/family carer will be included. If they show signs of cognitive impairment, they will not be eligible for the interviews. Informal carers will be included in the study if they are ≥18 years old and are fluent in Portuguese. They will be excluded if they show signs of cognitive impairment. Health professionals will be included if they contact with people with CRD in their clinical practice.

Sociodemographic and general clinical data will be collected. Instruments assessing cognitive impairment, functional capacity, disease's impact, health related quality of life, health status, level of anxiety and depression, satisfaction with life, social network, functionality, burden, positive aspects of caregiving, preparedness for caregiving, health literacy and informal carers' needs, as well as questions regarding care, will be applied. Interviews will be conducted.

Sample size will be determined by the saturation of qualitative data in task 2. For the assessment of health literacy of informal carers of people with CRD, it is not possible to determine the sample number. The maximum number of informal carers will be recruited and estimates a posteriori will be made. For task 3, following the Consensus-based Standards guidelines for the Selection of health status Measurement Instruments (COSMIN), a minimum of 100 participants will be required.

Data analysis will be conducted using the Statistical Package for the Social Sciences (SPSS) software. For the organization and visualization/analysis of qualitative data, the NVivo program will be used. Descriptive statistics, comparison of distributions, and associations. Validity and reliability will be assessed. The analysis of qualitative data will be divided into content analysis and thematic analysis.

02

Conditions studied

  • Chronic Respiratory Disease

Keywords

  • chronic respiratory disease
  • needs
  • informal care
  • loved ones
  • health literacy
  • measurement properties
  • preparedness for caregiving
03

In context

Lead sponsor

Aveiro University is the lead sponsor of 59 studies on the registry; 14 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

People with chronic respiratory diseases, informal carers of people with chronic respiratory diseases, and health professionals

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • People with chronic respiratory diseases (CRD):

    • 18 years of age or older;
    • Diagnosed with ILD, , lung cancer, severe asthma or bronchiectasis;
    • Fluent in Portuguese;
    • Identify an informal/family carer;
  • Informal carers of people with CRD:

    • 18 years of age or older;
    • Fluent in Portuguese.
  • Health Professionals:

    • Fluent in Portuguese;
    • Contact with people with CRD in their clinical practice.

Exclusion criteria

Exclusion Criteria:

  • People with CRD:

    • Signs of cognitive impairment in the Six-item Cognitive Impairment Test (6CIT) for the interviews.
  • Informal carers of people with CRD:

    • Signs of cognitive impairment in the 6CIT.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
250 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Preparedness for Caregiving Scale (PCS)

    The PCS was developed to assess the competence/level of preparation of informal/family carers (family member or friend) of elderly people with moderate to severe cognitive or physical decline at home.The scale has 8 items, scored on a 5-point scale (from 0 - "not at all prepared" to 4 - "very well prepared"). The total score varies from 0 to 32, with a higher score corresponding to a better perception of level of preparation It has shown good measurement properties. It will be translated and culturally adapted and applied to informal carers of people with CRD.

    Time frame: Task 2 and 3 (baseline)

Secondary outcomes

  1. Six Minute Walk Test (6MWT)

    The 6MWT is the gold standard exercise test and is commonly used to assess functional status.It is a valid and reliable measure in CRD. It will be used to characterize participants with CRD.

    Time frame: Task 2 and 3 (baseline)

  2. : Chronic Airways Assessment Test (CAAT)

    CAAT is a change to the COPD Assessment Test (CAT) so that it can be applied to people with COPD and/or asthma.It assesses diseases' impact, presenting 8 items related to respiratory symptoms (cough, chest symptoms and impacts on well-being and day-to-day, related to dyspnea, activity limitation, confidence to leave home, sleep and energy level), classified from 0 to 5. The total score is calculated by adding the score of the 8 items, ranging from 0 to 40 points, with a higher score corresponding to a greater impact of the disease. The total score can be divided into 4 levels: 1) low, 2) moderate, 3) high and 4) very high impact. The CAAT proved to be valid and reliable for people with COPD and/or asthma. Similarly, the CAT is a valid and reliable instrument, capable of discriminating people with different degrees of severity of COPD and has been used in different CRD. It will be used to characterize participants with CRD.

    Time frame: Task 2 and 3 (baseline)

  3. King's Brief Interstitial Lung Disease (KBILD)

    The KBILD was the first questionnaire developed to evaluate health related quality of life (HRQoL) in adults with insterstitial lung disease (ILD). It is easy to administer/ (5 to 7 minutes), economic and with excellent measurement properties. It consists of 15 items with a Likert scale of 7 points \[1 - always 7 - never (items 1, 2, 3, 4, 6, 14); 1 - never 7 - always (item 5); 1 - significantly 7 - not at all (item 15)\]. The total score and/or the score by domain (psychological, dyspnoea and activities, and chest symtpoms) can be calculated. The scores are transformed logarithmically, ranging from 0 to 100, and a higher score corresponds to a better perception of HRQoL. It will be used to characterize participants with ILD.

    Time frame: Task 2 and 3 (baseline)

  4. 5-level EuroQoL-5D (EQ-5D-5L)

    The EQ-5D-5L was developed by the EuroQol group to assess the perception of a person's current health status. It includes 5 dimensions (mobility, personal care, usual activities, pain, anxiety/depression) with 5 response levels (no problems, mild, moderate, severe or extreme problems). It also includes a vertical visual analogue scale (EQ VAS), which quantifies the perception of health status, ranging from 0 ("the worst health you can imagine") to 100 ("the best health you can imagine"). Its score can be transformed into Quality Adjusted Life Years and used for cost-utility analyses. The EQ-5D-5L is a simple to use, valid, reliable and responsive measure. It will be applied to people with CRD and their informal carers.

    Time frame: Task 2 and 3 (baseline)

  5. Hospital Anxiety and Depression Scale (HADS)

    The HADS was developed with the aim of providing health professionals with a reliable, valid and easy-to-use measure to identify and quantify the level of depression and anxiety.It consists of two subscales, which are scored separately: one for anxiety (seven items) and one for depression (seven items). Each item is scored from 0 to 3 points, so each subscale varies between 0 and 21 points. A score between 0 and 7 is 'normal', between 8 and 10 shows "light" level, between 11 and 14 "moderate" level, and between 15 and 21 "severe" level of anxiety/depression. It will be applied to people with CRD and their informal carers.

    Time frame: Task 2 and 3 (baseline)

  6. Satisfaction with life scale (SWLS)

    The SWLS was developed to measure overall satisfaction with life as a cognitive component of well-being. The scale presents 5 items, scored from 1 (totally disagrees) to 7 (totally agrees), and the score varies from 5 to 35, with a higher score corresponding to a greater satisfaction with life. It is a widely used instrument and is valid, reliable and can be used in different age groups. It will be applied to people with CRD and their informal carers.

    Time frame: Task 2 and 3 (baseline)

  7. Lubben Social Network Scale - 6 items (LSNS-6)

    The LSNS-6 is a reduced version of the Lubben Scale of Social Networks, which was developed for the assessment of social networks in the elderly population. The score varies from 0 to 30, and a higher score corresponds to a greater social network. A score of less than 12 corresponds to social isolation. It is used internationally and is valid and reliable. It will be applied to people with CRD and their informal carers.

    Time frame: Task 2 and 3 (baseline)

  8. World Health Organization Disability Assessment Schedule (WHODAS 2.0)

    The WHODAS 2.0 was developed by the World Health Organization as a general measure of functionality and disability, is based on the concepts of the International Classification of Functioning, Disability and Health. It captures the level of functionality in 6 domains: cognition, mobility, self-care, interaction with others, day-to-day activities, and participation in society.(from 0 - no difficulty to 4 - extreme difficulty or can not do). A higher score corresponds to a worse level of functionality. It is a simple and easy to apply (5 minutes) measure, being valid and reliable. It will be applied to people with CRD and their informal carers.

    Time frame: Task 2 and 3 (baseline)

  9. Zarit Burden Interview (ZBI-22)

    The ZBI-22 is used to assess the perception of informal carers regarding the impact of the disease on their lives, health and well-being, and social and financial life. It is composed of 22 assertions, scored from 0 (never) to 4 (almost always). The total score ranges from 0 to 88 and a higher score indicates greater burden. It is used worlwide in different contexts. It will be applied to informal carers of people with CRD.

    Time frame: Task 2 and 3 (baseline)

  10. Positive Aspects of Caregiving (PAC)

    The PAC scale reflects the positive aspects of caring for someone, as an informal/family carer,being an adaptation of the Caregiver Satisfaction Scale. It includes 11 items, scored from 1 (disagree a lot) to 5 (agree a lot). The score varies from 11 to 55, and a higher score corresponds to a better perception of the experience as an informal/family carer. It has been used in different contexts and has good measurement properties. It will be applied to informal carers of people with CRD.

    Time frame: Task 2 and 3 (baseline)

  11. European Health Literacy Survey - 47 items (HLS-EU-Q47)

    The HLS-EU-Q47 was developed to assess health literacy considering the current definition of this concept. It consists of 47 items, integrating 3 domains (health care, health promotion and disease prevention) and 4 levels of information processing (access, understanding, evaluation and use). The analysis of health literacy is performed in 12 sub-indexes, which are scored on a 4-point scale (very difficult, difficult, easy, very easy). A higher score corresponds to better health literacy. It will be applied to informal carers of people with CRD.

    Time frame: Task 2 and 3 (baseline)

  12. Carer Support Needs Assessment Tool (CSNAT)

    The CNSAT was developed to assess the needs of informal carers of people with cancer in the terminal phase. This measure has 5 phases: 1. introduction of the instrument; 2. completion of the instrument in its 15 domains; 3. an interview/guided conversation between the carer and the health professional, in which the needs of the carer are identified and prioritized; 4. adaptation solutions to the priorities; 5. review of the results. The process is then repeated at an agreed moment. It is valid and sensitive to change. It will be applied to informal carers of people with CRD and used as content validity to the instrument that will be developed in this project.

    Time frame: Task 2 and 3 (baseline)

  13. Qualitative data: interviews

    People with CRD and their informal carers, as well as health professionals, may participate in a interview in order to identify, understand and prioritize the needs of informal carers of people with CRD. Data from the interviews will be compared. For the development of the new instrument, individual cognitive interviews will be conducted with informal carers of people with CRD to refine its final version.

    Time frame: Task 2 and 3 (baseline)

  14. Social connectedness and care-related questions

    People with CRD and their informal carers: Geographical proximity to most of the social network; Social participation; Number of people providing informal care; Type of support received/provided; Relationship with the care provider/recipient; How good is the relationship with the care provider/recipient; Do you live with the care provider/recipient; Hours spent receiving/providing informal care per week; Frequency of informal care received/provided per week; Duration of informal care received/provided; Do you provide care to someone; People with CRD: Formal/informal care; Types of formal care; Hours spent receiving formal care per week; Satisfaction with informal care received Informal Carers of people with CRD: Recognised informal care status; Number of people providing care for; Impact on job/work due to caring for someone; Impact on sleep due to caring for someone

    Time frame: Task 2 and 3 (baseline)

  15. Brief Physical Activity Assessment Tool (BPAAT)

    The BPAAT was developed for healthcare professionals to identify inactive people in primary health care, identifying people who are sufficiently or insufficiently active. It consists of 2 questions: one on vigorous physical activity and the other on moderate physical activity, during an usual week. A total score ranges from 0 to 8 ( a score from 0 to 3 - not sufficiently active; and a score ≥4 - sufficiently active). It is easy to apply (5 minutes) and it is a valid and reliable measure, including for people with COPD. It will be applied to people with CRD and their informal carers.

    Time frame: Task 2 and 3 (baseline)

Other outcomes

  1. Sociodemographic data

    People with CRD: Sex; Age; Year of birth; Level of education; Occupation; Type of employment contract; Marital status; Municipality; Area of residence; Home ownership; Type of housing; Physical modifications to the house due to the CRD; Religious affiliation; Race;Socio-economic status (gross monthly income) Informal carers of people with CRD: Sex; Age; Year of birth; Level of education; Occupation; Type of employment contract; Marital status; Municipality; Area of residence; Home ownership; Type of housing; Religious affiliation; Race;Socio-economic status (gross monthly income) Health professionals: Sex; Age; Year of birth; Level of education; Specialisation

    Time frame: Task 2 and 3 (baseline)

  2. Clinical data

    People with CRD: Cognitive status (6-item cognitive impairment test); Diagnosis; Year of diagnosis; Disease stage; Lung function; Smoking status; Long-term Oxygen Therapy; Non-invasive ventilation; Comorbidities; Medication; Healthcare utilisation in the previous year; Number of exacerbations in previous year; Number of falls; Mobility aids Informal carerss of people with CRD: Smoking status; Comorbidities; Medication; Healthcare utilisation in the previous year; Number of falls

    Time frame: Task 2 and 3 (baseline)

  3. Anthropometric data

    People with CRD and their informal carers: height (meters); weight (Kg); Body mass index (kg/m\^2)

    Time frame: Task 2 and 3 (baseline)

  4. Contact with people with CRD

    Health professionals: Duration of contact with peple with CRD in clinical practice

    Time frame: Task 2 (baseline)

07

Study locations

1 site
08

References and documents

Publications

  • GBD 2019 Chronic Respiratory Diseases Collaborators. Global burden of chronic respiratory diseases and risk factors, 1990-2019: an update from the Global Burden of Disease Study 2019. EClinicalMedicine. 2023 May;59:101936. doi: 10.1016/j.eclinm.2023.101936. PubMed 37229504 ↗
  • Kaptain RJ, Helle T, Patomella AH, Weinreich UM, Kottorp A. New Insights into Activities of Daily Living Performance in Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis. 2021 Jan 7;16:1-12. doi: 10.2147/COPD.S264365. eCollection 2021. PubMed 33447024 ↗
  • Nakazawa A, Cox NS, Holland AE. Current best practice in rehabilitation in interstitial lung disease. Ther Adv Respir Dis. 2017 Feb;11(2):115-128. doi: 10.1177/1753465816676048. Epub 2016 Nov 15. PubMed 28150539 ↗
  • Lee JYT, Tikellis G, Corte TJ, Goh NS, Keir GJ, Spencer L, Sandford D, Khor YH, Glaspole I, Price J, Hey-Cunningham AJ, Maloney J, Teoh AKY, Watson AL, Holland AE. The supportive care needs of people living with pulmonary fibrosis and their caregivers: a systematic review. Eur Respir Rev. 2020 Apr 29;29(156):190125. doi: 10.1183/16000617.0125-2019. Print 2020 Jun 30. PubMed 32350085 ↗
  • Pena-Longobardo LM, Oliva-Moreno J, Hidalgo-Vega A, Miravitlles M. Economic valuation and determinants of informal care to disabled people with Chronic Obstructive Pulmonary Disease (COPD). BMC Health Serv Res. 2015 Mar 15;15:101. doi: 10.1186/s12913-015-0759-6. PubMed 25889556 ↗
  • Dzingina MD, Reilly CC, Bausewein C, Jolley CJ, Moxham J, McCrone P, Higginson IJ, Yi D. Variations in the cost of formal and informal health care for patients with advanced chronic disease and refractory breathlessness: A cross-sectional secondary analysis. Palliat Med. 2017 Apr;31(4):369-377. doi: 10.1177/0269216317690994. Epub 2017 Feb 13. PubMed 28190370 ↗
  • Macdonald MT, Lang A, Storch J, Stevenson L, Barber T, Iaboni K, Donaldson S. Examining markers of safety in homecare using the international classification for patient safety. BMC Health Serv Res. 2013 May 24;13:191. doi: 10.1186/1472-6963-13-191. PubMed 23705841 ↗
  • Cruz J, Marques A, Figueiredo D. Impacts of COPD on family carers and supportive interventions: a narrative review. Health Soc Care Community. 2017 Jan;25(1):11-25. doi: 10.1111/hsc.12292. Epub 2015 Oct 26. PubMed 26499310 ↗
  • Trivedi RB, Bryson CL, Udris E, Au DH. The influence of informal caregivers on adherence in COPD patients. Ann Behav Med. 2012 Aug;44(1):66-72. doi: 10.1007/s12160-012-9355-8. PubMed 22422104 ↗
  • Kong YL, Anis-Syakira J, Jawahir S, R'ong Tan Y, Rahman NHA, Tan EH. Factors associated with informal caregiving and its effects on health, work, and social activities of adult informal caregivers in Malaysia: findings from the National Health and Morbidity Survey 2019. BMC Public Health. 2021 Jun 1;21(1):1033. doi: 10.1186/s12889-021-11022-1. PubMed 34074275 ↗
  • Terwee CB, Prinsen CAC, Chiarotto A, Westerman MJ, Patrick DL, Alonso J, Bouter LM, de Vet HCW, Mokkink LB. COSMIN methodology for evaluating the content validity of patient-reported outcome measures: a Delphi study. Qual Life Res. 2018 May;27(5):1159-1170. doi: 10.1007/s11136-018-1829-0. Epub 2018 Mar 17. PubMed 29550964 ↗
  • Health measurement scales: a practical guide to their development and use (5th edition). Aust N Z J Public Health. 2016 Jun;40(3):294-5. doi: 10.1111/1753-6405.12484. No abstract available. PubMed 27242256 ↗
  • Apostolo JLA, Paiva DDS, Silva RCGD, Santos EJFD, Schultz TJ. Adaptation and validation into Portuguese language of the six-item cognitive impairment test (6CIT). Aging Ment Health. 2018 Sep;22(9):1184-1189. doi: 10.1080/13607863.2017.1348473. Epub 2017 Jul 25. PubMed 28741373 ↗
  • ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002 Jul 1;166(1):111-7. doi: 10.1164/ajrccm.166.1.at1102. No abstract available. PubMed 12091180 ↗
  • Tomaszewski EL, Atkinson MJ, Janson C, Karlsson N, Make B, Price D, Reddel HK, Vogelmeier CF, Mullerova H, Jones PW; NOVELTY Scientific Community; NOVELTY study investigators. Chronic Airways Assessment Test: psychometric properties in patients with asthma and/or COPD. Respir Res. 2023 Apr 8;24(1):106. doi: 10.1186/s12931-023-02394-6. PubMed 37031164 ↗
  • Patel AS, Siegert RJ, Brignall K, Gordon P, Steer S, Desai SR, Maher TM, Renzoni EA, Wells AU, Higginson IJ, Birring SS. The development and validation of the King's Brief Interstitial Lung Disease (K-BILD) health status questionnaire. Thorax. 2012 Sep;67(9):804-10. doi: 10.1136/thoraxjnl-2012-201581. Epub 2012 May 3. PubMed 22555278 ↗
  • Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, Bonsel G, Badia X. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011 Dec;20(10):1727-36. doi: 10.1007/s11136-011-9903-x. Epub 2011 Apr 9. PubMed 21479777 ↗
  • Pais-Ribeiro J, Silva I, Ferreira T, Martins A, Meneses R, Baltar M. Validation study of a Portuguese version of the Hospital Anxiety and Depression Scale. Psychol Health Med. 2007 Mar;12(2):225-35; quiz 235-7. doi: 10.1080/13548500500524088. English, Portuguese. PubMed 17365902 ↗
  • Diener E, Emmons RA, Larsen RJ, Griffin S. The Satisfaction With Life Scale. J Pers Assess. 1985 Feb;49(1):71-5. doi: 10.1207/s15327752jpa4901_13. PubMed 16367493 ↗
  • Lubben J, Blozik E, Gillmann G, Iliffe S, von Renteln Kruse W, Beck JC, Stuck AE. Performance of an abbreviated version of the Lubben Social Network Scale among three European community-dwelling older adult populations. Gerontologist. 2006 Aug;46(4):503-13. doi: 10.1093/geront/46.4.503. PubMed 16921004 ↗
  • Zarit SH, Reever KE, Bach-Peterson J. Relatives of the impaired elderly: correlates of feelings of burden. Gerontologist. 1980 Dec;20(6):649-55. doi: 10.1093/geront/20.6.649. No abstract available. PubMed 7203086 ↗
  • Kusier AO, Folker AP. The Satisfaction with Life Scale: Philosophical Foundation and Practical Limitations. Health Care Anal. 2021 Mar;29(1):21-38. doi: 10.1007/s10728-020-00420-y. Epub 2021 Jan 2. PubMed 33386535 ↗
  • Lee Y, Li L. Evaluating the Positive Experience of Caregiving: A Systematic Review of the Positive Aspects of Caregiving Scale. Gerontologist. 2022 Oct 19;62(9):e493-e507. doi: 10.1093/geront/gnab092. PubMed 34216215 ↗
  • Archbold PG, Stewart BJ, Greenlick MR, Harvath T. Mutuality and preparedness as predictors of caregiver role strain. Res Nurs Health. 1990 Dec;13(6):375-84. doi: 10.1002/nur.4770130605. PubMed 2270302 ↗
  • Sorensen K, Pelikan JM, Rothlin F, Ganahl K, Slonska Z, Doyle G, Fullam J, Kondilis B, Agrafiotis D, Uiters E, Falcon M, Mensing M, Tchamov K, van den Broucke S, Brand H; HLS-EU Consortium. Health literacy in Europe: comparative results of the European health literacy survey (HLS-EU). Eur J Public Health. 2015 Dec;25(6):1053-8. doi: 10.1093/eurpub/ckv043. Epub 2015 Apr 5. PubMed 25843827 ↗
  • Ewing G, Grande G; National Association for Hospice at Home. Development of a Carer Support Needs Assessment Tool (CSNAT) for end-of-life care practice at home: a qualitative study. Palliat Med. 2013 Mar;27(3):244-56. doi: 10.1177/0269216312440607. Epub 2012 Mar 26. PubMed 22450160 ↗
  • Cruz J, Jacome C, Oliveira A, Paixao C, Rebelo P, Flora S, Januario F, Valente C, Andrade L, Marques A. Construct validity of the brief physical activity assessment tool for clinical use in COPD. Clin Respir J. 2021 May;15(5):530-539. doi: 10.1111/crj.13333. Epub 2021 Feb 15. PubMed 33484059 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jun 2024 (actual). Primary completion is estimated for Dec 2027, 42 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 9, 2024
First posted
Jun 14, 2024
StartActual
Jun 24, 2024
Primary completionEst.
Dec 31, 2027
CompletionEst.
Jul 31, 2028
Last update
Oct 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Enrolling by invitation
changed Oct 27, 2026
Sites
1 site added, 1 site removed
Show site
  • University of Aveiro · Aveiro, Portugal
Show 1 removed
  • University of Aveiro · Aveiro, Portugal
Oct 27, 2026
Contact
No study contact listed any more: removed a•••@ua.pt · •••2462; removed o•••@ua.pt · •••2476
Oct 27, 2026
Show all 1 update
  1. Oct 27, 2026
    Recruiting→Enrolling by invitation
    1 site added, 1 site removed
    Show site
    • University of Aveiro · Aveiro, Portugal
    Show 1 removed
    • University of Aveiro · Aveiro, Portugal
    Contact No study contact listed any more: removed a•••@ua.pt · •••2462; removed o•••@ua.pt · •••2476
    + 3 other changes: index terms, verification date and references

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06459011
Lead sponsor
Aveiro University
Collaborators
Fundação para a Ciência e a Tecnologia
Responsible party
Alda Sofia Pires de Dias Marques (Senior Lecturer, Aveiro University) — Principal investigator
First posted
Jun 14, 2024
Start date
Jun 24, 2024
Primary completion
Dec 31, 2027 (estimated)
Completion
Jul 31, 2028 (estimated)
Last update
Oct 27, 2026

Study contacts

Alda S Marques, PhD
principal investigator · School of Health Sciences of the University of Aveiro (ESSUA)

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion